Exogenous Lysyl Oxidase-Like 2 and Perfusion Culture Induce Collagen Crosslink Formation in Osteogenic Grafts

Debika Mitra, Osamu W. Yasui, Jenna N. Harvestine, Jarrett M. Link, Jerry C. Hu, Kyriacos A. Athanasiou, Jonathan K Leach

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Lysyl oxidase (LOX)-mediated collagen crosslinking can regulate osteoblastic phenotype and enhance mechanical properties of tissues, both areas of interest in bone tissue engineering. The objective of this study is to investigate the effect of lysyl oxidase-like 2 (LOXL2) on osteogenic differentiation of mesenchymal stem cells (MSCs) cultured in perfusion bioreactors, enzymatic collagen crosslink formation in the extracellular matrix (ECM), and mechanical properties of engineered bone grafts. Exogenous LOXL2 to MSCs seeded in composite scaffolds under perfusion culture for up to 28 days is administered. Constructs treated with LOXL2 appear brown in color and possess greater DNA content and osteogenic potential measured by a twofold increase in bone sialoprotein gene expression. Collagen expression of LOXL2-treated scaffolds is lower than untreated controls. Functional outputs such as calcium deposition, osteocalcin expression, and compressive modulus are unaffected by LOXL2 supplementation. Excitingly, LOXL2-treated constructs contain 1.8- and 1.4-times more pyridinoline (PYD) crosslinks per mole of collagen and per wet weight, respectively, than untreated constructs. Despite these increases, compressive moduli of LOXL2-treated constructs are similar to untreated constructs over the 28-day culture duration. This is the first report of LOXL2 application to engineered, three-dimensional bony constructs. The results suggest a potentially new strategy for engineering osteogenic grafts with a mature ECM by modulating crosslink formation.

Original languageEnglish (US)
JournalBiotechnology Journal
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Protein-Lysine 6-Oxidase
Collagen
Perfusion
Transplants
Mesenchymal Stromal Cells
Extracellular Matrix
Integrin-Binding Sialoprotein
Bone and Bones
Osteocalcin
Bioreactors
Tissue Engineering
Color
Calcium
Phenotype
Gene Expression

Keywords

  • bone engineering
  • collagen crosslinks
  • mesenchymal stem cells
  • perfusion cultures
  • pyridinoline

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Molecular Medicine

Cite this

Mitra, D., Yasui, O. W., Harvestine, J. N., Link, J. M., Hu, J. C., Athanasiou, K. A., & Leach, J. K. (Accepted/In press). Exogenous Lysyl Oxidase-Like 2 and Perfusion Culture Induce Collagen Crosslink Formation in Osteogenic Grafts. Biotechnology Journal. https://doi.org/10.1002/biot.201700763

Exogenous Lysyl Oxidase-Like 2 and Perfusion Culture Induce Collagen Crosslink Formation in Osteogenic Grafts. / Mitra, Debika; Yasui, Osamu W.; Harvestine, Jenna N.; Link, Jarrett M.; Hu, Jerry C.; Athanasiou, Kyriacos A.; Leach, Jonathan K.

In: Biotechnology Journal, 01.01.2018.

Research output: Contribution to journalArticle

Mitra, Debika ; Yasui, Osamu W. ; Harvestine, Jenna N. ; Link, Jarrett M. ; Hu, Jerry C. ; Athanasiou, Kyriacos A. ; Leach, Jonathan K. / Exogenous Lysyl Oxidase-Like 2 and Perfusion Culture Induce Collagen Crosslink Formation in Osteogenic Grafts. In: Biotechnology Journal. 2018.
@article{3dc4c7e87f8746e494e7bf73a3c31315,
title = "Exogenous Lysyl Oxidase-Like 2 and Perfusion Culture Induce Collagen Crosslink Formation in Osteogenic Grafts",
abstract = "Lysyl oxidase (LOX)-mediated collagen crosslinking can regulate osteoblastic phenotype and enhance mechanical properties of tissues, both areas of interest in bone tissue engineering. The objective of this study is to investigate the effect of lysyl oxidase-like 2 (LOXL2) on osteogenic differentiation of mesenchymal stem cells (MSCs) cultured in perfusion bioreactors, enzymatic collagen crosslink formation in the extracellular matrix (ECM), and mechanical properties of engineered bone grafts. Exogenous LOXL2 to MSCs seeded in composite scaffolds under perfusion culture for up to 28 days is administered. Constructs treated with LOXL2 appear brown in color and possess greater DNA content and osteogenic potential measured by a twofold increase in bone sialoprotein gene expression. Collagen expression of LOXL2-treated scaffolds is lower than untreated controls. Functional outputs such as calcium deposition, osteocalcin expression, and compressive modulus are unaffected by LOXL2 supplementation. Excitingly, LOXL2-treated constructs contain 1.8- and 1.4-times more pyridinoline (PYD) crosslinks per mole of collagen and per wet weight, respectively, than untreated constructs. Despite these increases, compressive moduli of LOXL2-treated constructs are similar to untreated constructs over the 28-day culture duration. This is the first report of LOXL2 application to engineered, three-dimensional bony constructs. The results suggest a potentially new strategy for engineering osteogenic grafts with a mature ECM by modulating crosslink formation.",
keywords = "bone engineering, collagen crosslinks, mesenchymal stem cells, perfusion cultures, pyridinoline",
author = "Debika Mitra and Yasui, {Osamu W.} and Harvestine, {Jenna N.} and Link, {Jarrett M.} and Hu, {Jerry C.} and Athanasiou, {Kyriacos A.} and Leach, {Jonathan K}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/biot.201700763",
language = "English (US)",
journal = "Biotechnology Journal",
issn = "1860-6768",
publisher = "Wiley-VCH Verlag",

}

TY - JOUR

T1 - Exogenous Lysyl Oxidase-Like 2 and Perfusion Culture Induce Collagen Crosslink Formation in Osteogenic Grafts

AU - Mitra, Debika

AU - Yasui, Osamu W.

AU - Harvestine, Jenna N.

AU - Link, Jarrett M.

AU - Hu, Jerry C.

AU - Athanasiou, Kyriacos A.

AU - Leach, Jonathan K

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Lysyl oxidase (LOX)-mediated collagen crosslinking can regulate osteoblastic phenotype and enhance mechanical properties of tissues, both areas of interest in bone tissue engineering. The objective of this study is to investigate the effect of lysyl oxidase-like 2 (LOXL2) on osteogenic differentiation of mesenchymal stem cells (MSCs) cultured in perfusion bioreactors, enzymatic collagen crosslink formation in the extracellular matrix (ECM), and mechanical properties of engineered bone grafts. Exogenous LOXL2 to MSCs seeded in composite scaffolds under perfusion culture for up to 28 days is administered. Constructs treated with LOXL2 appear brown in color and possess greater DNA content and osteogenic potential measured by a twofold increase in bone sialoprotein gene expression. Collagen expression of LOXL2-treated scaffolds is lower than untreated controls. Functional outputs such as calcium deposition, osteocalcin expression, and compressive modulus are unaffected by LOXL2 supplementation. Excitingly, LOXL2-treated constructs contain 1.8- and 1.4-times more pyridinoline (PYD) crosslinks per mole of collagen and per wet weight, respectively, than untreated constructs. Despite these increases, compressive moduli of LOXL2-treated constructs are similar to untreated constructs over the 28-day culture duration. This is the first report of LOXL2 application to engineered, three-dimensional bony constructs. The results suggest a potentially new strategy for engineering osteogenic grafts with a mature ECM by modulating crosslink formation.

AB - Lysyl oxidase (LOX)-mediated collagen crosslinking can regulate osteoblastic phenotype and enhance mechanical properties of tissues, both areas of interest in bone tissue engineering. The objective of this study is to investigate the effect of lysyl oxidase-like 2 (LOXL2) on osteogenic differentiation of mesenchymal stem cells (MSCs) cultured in perfusion bioreactors, enzymatic collagen crosslink formation in the extracellular matrix (ECM), and mechanical properties of engineered bone grafts. Exogenous LOXL2 to MSCs seeded in composite scaffolds under perfusion culture for up to 28 days is administered. Constructs treated with LOXL2 appear brown in color and possess greater DNA content and osteogenic potential measured by a twofold increase in bone sialoprotein gene expression. Collagen expression of LOXL2-treated scaffolds is lower than untreated controls. Functional outputs such as calcium deposition, osteocalcin expression, and compressive modulus are unaffected by LOXL2 supplementation. Excitingly, LOXL2-treated constructs contain 1.8- and 1.4-times more pyridinoline (PYD) crosslinks per mole of collagen and per wet weight, respectively, than untreated constructs. Despite these increases, compressive moduli of LOXL2-treated constructs are similar to untreated constructs over the 28-day culture duration. This is the first report of LOXL2 application to engineered, three-dimensional bony constructs. The results suggest a potentially new strategy for engineering osteogenic grafts with a mature ECM by modulating crosslink formation.

KW - bone engineering

KW - collagen crosslinks

KW - mesenchymal stem cells

KW - perfusion cultures

KW - pyridinoline

UR - http://www.scopus.com/inward/record.url?scp=85052468345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052468345&partnerID=8YFLogxK

U2 - 10.1002/biot.201700763

DO - 10.1002/biot.201700763

M3 - Article

C2 - 30052320

AN - SCOPUS:85052468345

JO - Biotechnology Journal

JF - Biotechnology Journal

SN - 1860-6768

ER -